|
PRELIMINARY TABLE OF CONTENTS
AND LIST OF EXHIBITS
EXECUTIVE SUMMARY
i. European Healthcare Markets
ii. Musculoskeletal System Overview
iii. Orthopedic
Tissue Grafts, Placement Volumes and Products Markets
iv. Bone Graft
Substitutes, Placement Volumes and Products Markets
v. Bone Growth
Factors, Placement Volumes and Products Markets
vi. Arthroscopic
Devices, Placement Volumes and Products Markets
1. EUROPEAN
HEALTHCARE MARKET OVERVIEW
1.1 The European
Union
1.1.1 A Common Currency
1.1.2 Regulatory Policies
1.1.3 Reimbursement
1.1.4 Factors Affecting Healthcare Delivery
1.1.4.1 Aging Population
1.1.4.2 Cost Containment
1.1.4.3 Industry Consolidation
1.1.4.4 Managed Care
1.1.5 Healthcare Spending
1.2 Selected
European National Healthcare Profiles
1.2.1
France
1.2.1.1 Healthcare Organization and Reform
1.2.1.2 Hospital
Services
1.2.1.3 Medical Device Reimbursement
1.2.2
Germany
1.2.2.1 Healthcare Organization and Reform
1.2.2.2 Hospital
Services
1.2.2.3 Medical Device Reimbursement
1.2.3
Italy
1.2.3.1 Healthcare Organization and Reform
1.2.3.2 Hospital
Services
1.2.3.3 Medical Device Reimbursement
1.2.4
Spain
1.2.4.1 Healthcare Organization and Reform
1.2.4.2 Hospital
Services
1.2.4.3 Medical Device Reimbursement
1.2.5
United Kingdom
1.2.5.1 Healthcare Organization and Reform
1.2.5.2 Hospital
Services
1.2.5.3 Medical Device Reimbursement
1.2.6 Rest of
Europe
1.2.6.1 Healthcare Organization and Reform
1.2.6.2 Hospital
Services
1.2.6.3 Medical Device Reimbursement
Exhibit 1-1:
European Union, Medical Devices Risk Classification System
Exhibit 1-2:
European Union, Population Statistics Comparison, 1994 and 2004
Exhibit 1-3:
France, Selected National Healthcare Statistics
Exhibit 1-4:
Germany, Selected National Healthcare Statistics
Exhibit 1-5:
Italy, Selected National Healthcare Statistics
Exhibit 1-6:
Spain, Selected National Healthcare Statistics
Exhibit 1-7:
United Kingdom, Selected National Healthcare Statistics
2.
MUSCULOSKELETAL SYSTEM OVERVIEW
2.1 Bone
Structure and Function
2.1.1 Cells
2.1.1.1 Osteoblasts
2.1.1.2 Osteocytes
2.1.1.3 Osteoclasts
2.1.2 Tissues
2.1.2.1 Compact Bone
2.1.2.2 Spongy Bone
2.1.2.3 Bone Marrow
2.1.2.4 Endosteum
2.1.2.5 Periosteum
2.1.3 Bone
Formation and Resorption
2.1.3.1 In the Fetus
2.1.3.2 In Childhood
2.1.3.3 In Adulthood
2.1.3.4 In Old Age
2.1.3.5 Mechanical Stress and Wolff’s Law
2.1.4 Factors
Affecting Bone Physiology
2.1.4.1 Age
2.1.4.2 Gender
2.1.4.3 Genetic Disposition
2.1.4.4 Hormonal Activity
2.1.4.5 Physical Activity
2.1.4.6 Cigarette Smoking
2.1.4.7 Alcohol and Caffeine Intake
2.1.4.8 Nutritional Deficiencies
2.1.5 Selected
Diseases and Disorders that Affect Bones
2.1.5.1 Fractures
2.1.5.2 Osteoporosis
2.1.5.3 Osteosarcoma
2.1.5.4 Paget’s Disease
2.1.5.5 Rickets/Osteomalacia
2.2 Joint
Structure and Function
2.2.1 Types of
Joints
2.2.1.1 Synarthroses
2.2.1.2 Amphiarthroses
2.2.1.3 Diarthroses
2.2.1.3.1 Ball-and-Socket
2.2.1.3.2 Condyloid
2.2.1.3.3 Hinge
2.2.1.3.4 Gliding
2.2.1.3.5 Pivot
2.2.2 Joint
Components
2.2.2.1 Articular Cartilage
2.2.2.2 Bursae
2.2.2.3 Joint Cavity
2.2.2.4 Meniscus
2.2.2.5 Synovial Membrane and Fluid
2.2.2.6 Ligaments and Tendons
2.2.3 Selected
Diseases and Disorders that Affect Joints
2.2.3.1 Arthritis
2.2.3.1.1 Osteoarthritis
2.2.3.1.2 Rheumatoid Arthritis
2.2.3.2 Dislocation
2.3.3.3 Ligament and Tendon Injuries
2.3.3.4 Meniscal Injuries
2.3 Management of
Bone and Joint Disorders
2.3.1 Fracture
Management
2.3.2 Joint
Replacement
2.3.3 Arthroscopy
Exhibit 2-1: Illustration of Bone Tissue
Exhibit 2-2: Types of Cartilage
Exhibit 2-3: Classifications of Fractures
3. BIOMATERIALS IN ORTHOPEDIC
AND
ARTHROSCOPIC SURGERY APPLICATIONS
3.1 Introduction
to Biomaterials
3.1.1 Definition
of Biomaterials
3.1.2 Biomaterial
Sources
3.1.2.1
Biomaterials Derived from Living Tissues
3.1.2.2 Synthetic Biomaterials
3.1.2.2.1 Organic
3.1.2.2.2 Inorganic
3.1.2.3 Hybrid
Biomaterials
3.1.3
Biomaterials and Biocompatibility
3.1.3.1
Nonresorbable Biomaterials
3.1.3.2
Resorbable and Soluble Biomaterials
3.1.3.3 Host
Tissue Response to Biomaterials
3.1.4 Tissue
Engineering and the Use of Biomaterial Scaffolds
3.1.4.1 Scaffolds
for Bone Tissue Regeneration/Repair
3.1.4.2 Scaffolds
for Cartilage Tissue Regeneration/Repair
3.1.4.3 Scaffolds
for Meniscal Tissue Regeneration/Repair
3.1.4.4 Tissue
Engineering Techniques and Bone Growth Factors
3.1.4.5 Tissue
Engineering Techniques and Gene Therapy
3.2
Reconstructive Materials
3.2.1 Metals
3.2.1.1 Cobalt
Alloys
3.2.1.1.1 Structure and Properties
3.2.1.1.2 Tissue Response
3.2.1.1.3
Advantages and Disadvantages
3.2.1.2 Stainless
Steel Alloys
3.2.1.2.1
Structure and Properties
3.2.1.2.2 Tissue
Response
3.2.1.2.3
Advantages and Disadvantages
3.2.1.3 Titanium
Alloys
3.2.1.3.1
Structure and Properties
3.2.1.3.2 Tissue
Response
3.2.1.3.3
Advantages and Disadvantages
3.2.2 Ceramics
3.2.2.1 Aluminum
Oxides
3.2.2.1.1
Structure and Properties
3.2.2.2 Calcium
Phosphates
3.2.2.2.1
Structure and Properties
3.2.2.3 Glass
Ceramics
3.2.2.3.1
Structure and Properties
3.2.2.4 Tissue
Response to Ceramic Implant/Coating Materials
3.2.2.5
Advantages and Disadvantages of Ceramic Implant/Coating Materials
3.2.3 Polymers
3.2.3.1 Carbon
Fiber
3.2.3.1.1
Structure and Properties
3.2.3.2 Silicone
Rubber
3.2.3.2.1
Structure and Properties
3.2.3.3
Polyethylene
3.2.3.3.1
Structure and Properties
3.2.3.4
Polytetrafluoroethylene
3.2.3.4.1
Structure and Properties
3.2.3.5
Polyurethanes
3.2.3.5.1
Structure and Properties
3.2.3.6 Ultrahigh
Molecular-Weight Polyethylene
3.2.3.6.1
Structure and Properties
3.2.3.7 Tissue
Response to Polymer Implants
3.2.3.8
Advantages and Disadvantages
3.2.4 Resorbable
Materials
3.2.4.1
Polyglycolic Acid
3.2.4.2
Polylactic Acid
3.2.4.3
Copolymers
Exhibit 3-1:
2006, Selected Synthetic Biomaterials Used in Tissue Engineering and
Organ Replacement/Regeneration
Exhibit 3-2:
American Society for Testing and Materials D1418 Silicone Rubber
Classifications
4. ORTHOPEDIC
TISSUE GRAFTS MARKET
4.1 Types of
Tissue Grafts
4.1.1 Autografts
4.1.1.1
Advantages and Disadvantages of Use
4.1.2 Allografts
4.1.2.1
Advantages and Disadvantages of Use
4.1.3 Xenografts
4.1.3.1
Advantages and Disadvantages of Use
4.2 Bone
Allografts
4.2.1 Mechanisms
of Bone Graft Activity
4.2.1.1
Osteoconduction
4.2.1.2
Osteogenesis
4.2.1.3
Osteoinduction
4.2.2 Types of
Bone Allografts
4.2.2.1 Large and
Intercalary Allografts
4.2.2.1.1
Indications for Use
4.2.2.1.2
Products/Technologies
4.2.2.1.3
Placement Volumes Forecast
4.2.2.1.4 Market
Forecast
4.2.2.2 Bone
Dowels, Pins, Screws, and Wedges
4.2.2.2.1
Indications for Use
4.2.2.2.2
Products/Technologies
4.2.2.2.3
Placement Volumes Forecast
4.2.2.2.4 Market
Forecast
4.2.2.3 Machined
Cortical Bone Allografts
4.2.2.3.1
Indications for Use
4.2.2.3.2
Products/Technologies
4.2.2.3.3
Placement Volumes Forecast
4.2.2.3.4 Market
Forecast
4.2.2.4 Milled
and Blended Bone Allografts
4.2.2.4.1
Indications For Use
4.2.2.4.2
Products/Technologies
4.2.2.4.3
Placement Volumes Forecast
4.2.2.4.4 Market
Forecast
4.2.2.5
Osteoarticular Allografts
4.2.2.5.1
Indications for Use
4.2.2.5.2
Products/Technologies
4.2.2.5.3
Placement Volumes Forecast
4.2.2.5.4 Market
Forecast
4.3 Tendon and
Ligament Allografts
4.3.1 Indications
for Use
4.3.2
Products/Technologies
4.3.3 Placement
Volumes Forecast
4.3.4 Market
Forecast
4.4 Meniscus
Allografts
4.4.1 Indications
for Use
4.4.2
Products/Technologies
4.4.3 Placement
Volumes Forecast
4.4.4 Market
Forecast
4.5 Orthopedic
Tissue Grafts Market Analysis
4.5.1 Market
Forecasts
4.5.1.1 Europe
4.5.1.2 France
4.5.1.3 Germany
4.5.1.4 Italy
4.5.1.5 Spain
4.5.1.6 United
Kingdom
4.5.1.7 Rest of
Europe
4.5.2 Competitive
Analysis
4.5.2.1 Europe
4.5.2.2 France
4.5.2.3 Germany
4.5.2.4 Italy
4.5.2.5 Spain
4.5.2.6 United
Kingdom
4.5.2.7 Rest of
Europe
Exhibit 4-1:
Types of Bone Grafts
Exhibit 4-2:
2006, Base Tissue Bone Allografts Used in Orthopedic Surgical
Procedures
Exhibit 4-3:
Large and Intercalary Allograft Grafts, Market Forecast, 2004-2010
Exhibit 4-4:
2006, Types of Bioresorbable Fixation Products
Exhibit 4-5:
2006, Selected Bioresorbable Fixation Products
Exhibit 4-6:
Bones, Dowels, Pins, Screws, and Wedges Grafts, Market Forecast,
2004-2010
Exhibit 4-7:
2006, Major Indications for Bone Grafts
Exhibit 4-8:
2006, Selected Machined Cortical Allograft Implant Products
Exhibit 4-9:
Machined Cortical Bone Allografts, Market Forecast, 2004-2010
Exhibit 4-10:
Milled and Blended Bone Allograft Grafts, Market Forecast, 2004-2010
Exhibit 4-11:
Osteoarticular Allograft Grafts, Market Forecast, 2004-2010
Exhibit 4-12:
2006, Selected Emerging Polymer-Based Scaffolds for Ligament and
Tendon Repair
Exhibit 4-13:
Tendon and Ligament Allograft Grafts, Market Forecast, 2004-2010
Exhibit 4-14:
2006, Selected Emerging Meniscal Repair and Replacement Products
Exhibit 4-15:
Meniscus Allograft Grafts, Market Forecast, 2004-2010
Exhibit 4-16:
Orthopedic Tissue Grafts, European Market Forecast, 2004-2010
Exhibit 4-17:
Orthopedic Tissue Grafts, France Market Forecast, 2004-2010
Exhibit 4-18:
Orthopedic Tissue Grafts, Germany Market Forecast, 2004-2010
Exhibit 4-19:
Orthopedic Tissue Grafts, Italy Market Forecast, 2004-2010
Exhibit 4-20:
Orthopedic Tissue Grafts, Spain Market Forecast, 2004-2010
Exhibit 4-21:
Orthopedic Tissue Grafts, United Kingdom Market Forecast, 2004-2010
Exhibit 4-22:
Orthopedic Tissue Grafts, Rest of Europe Market Forecast, 2004-2010
Exhibit 4-23:
2005, European Market Orthopedic Tissue Grafts Market, Share by
Supplier
Exhibit 4-24:
2005, France Orthopedic Tissue Grafts Market, Share by Supplier
Exhibit 4-25:
2005, Germany Orthopedic Tissue Grafts Market, Share by Supplier
Exhibit 4-26:
2005, Italy Orthopedic Tissue Grafts Market, Share by Supplier
Exhibit 4-27:
2005, Spain Orthopedic Tissue Grafts Market, Share by Supplier
Exhibit 4-28:
2005, United Kingdom Orthopedic Tissue Grafts Market, Share by
Supplier
Exhibit 4-29:
2005, Rest of Europe Orthopedic Tissue Grafts Market, Share by
Supplier
5. BONE GRAFT
SUBSTITUTES MARKET
5.1 Bone Graft
Substitutes
5.1.1 Calcium
Phosphate Formulations
5.1.1.1
Products/Technologies
5.1.1.2 Placement
Volumes Forecast
5.1.1.3 Market
Forecast
5.1.2 Calcium
Sulfate Formulations
5.1.2.1
Products/Technologies
5.1.2.2 Placement
Volumes Forecast
5.1.2.3 Market
Forecast
5.1.3 Collagen
Formulations
5.1.3.1
Products/Technologies
5.1.3.2 Placement
Volumes Forecast
5.1.3.3 Market
Forecast
5.1.4
Demineralized Bone Matrix Formulations
5.1.4.1
Combination Products
5.1.4.2
Augmentation with Bone Marrow
5.1.4.3
Augmentation with Platelet Concentrate
5.1.4.4
Products/Technologies
5.1.4.5 Placement
Volumes Forecast
5.1.4.6 Market
Forecast
5.1.5
Hydroxyapatite Formulations
5.1.5.1
Products/Technologies
5.1.5.2 Placement
Volumes Forecast
5.1.5.3 Market
Forecast
5.1.6 Polymer
Products
5.1.6.1
Products/Technologies
5.1.6.2 Placement
Volumes Forecast
5.1.6.3 Market
Forecast
5.1.7 Composite
Formulations
5.1.7.1
Products/Technologies
5.1.7.2 Placement
Volumes Forecast
5.1.7.3 Market
Forecast
5.2 Bone Graft
Substitutes Market Analysis
5.2.1 Market
Forecasts
5.2.1.1 Europe
5.2.1.2 France
5.2.1.3 Germany
5.2.1.4 Italy
5.2.1.5 Spain
5.2.1.6 United
Kingdom
5.2.1.7 Rest of
Europe
5.2.2 Competitive
Analysis
5.2.2.1 France
5.2.2.2 Germany
5.2.2.3 Italy
5.2.2.4 Spain
5.2.2.5 United
Kingdom
5.2.2.6 Rest of
Europe
Exhibit 5-1:
Types of Bone Grafts
Exhibit 5-2:
2006, Materials Used in Commercially Available Synthetic Replacement
Products
Exhibit 5-3:
Calcium Phosphate Formulations, Market Forecast, 2004-2010
Exhibit 5-4:
Calcium Sulphate Formulations, Market Forecast, 2004-2010
Exhibit 5-5:
2006, Selected Biologically Derived Materials in Collagen
Formulations
Exhibit 5-6:
Collagen Formulations, Market Forecast, 2004-2010
Exhibit 5-7:
2006, Selected Demineralized Bone Matrix Products
Exhibit 5-8:
Demineralized Bone Matrix Formulations, Market Forecast, 2004-2010
Exhibit 5-9:
Hydroxyapatite Formulations, Market Forecast, 2004-2010
Exhibit 5-10:
Polymer Products, Market Forecast, 2004-2010
Exhibit 5-11:
Composite Formulations, Market Forecast, 2004-2010
Exhibit 5-12:
Bone Graft Substitutes, European Market Forecast, 2004-2010
Exhibit 5-13:
Bone Graft Substitutes, France Market Forecast, 2004-2010
Exhibit 5-14:
Bone Graft Substitutes, Germany Market Forecast, 2004-2010
Exhibit 5-15:
Bone Graft Substitutes, Italy Market Forecast, 2004-2010
Exhibit 5-16:
Bone Graft Substitutes, Spain Market Forecast, 2004-2010
Exhibit 5-17:
Bone Graft Substitutes, United Kingdom Market Forecast, 2004-2010
Exhibit 5-18:
Bone Graft Substitutes, Rest of Europe Market Forecast, 2004-20010
Exhibit 5-19:
2005, European Orthopedic Bone Graft Substitutes Market, Share by
Supplier
Exhibit 5-20:
2005, France Orthopedic Bone Graft Substitutes Market, Share by
Supplier
Exhibit 5-21:
2005, Germany Orthopedic Bone Graft Substitutes Market, Share by
Supplier
Exhibit 5-22:
2005, Italy Orthopedic Bone Graft Substitutes Market, Share by
Supplier
Exhibit 5-23:
2005, Spain Orthopedic Bone Graft Substitutes Market, Share by
Supplier
Exhibit 5-24:
2005, United Kingdom Orthopedic Bone Graft Substitutes Market, Share
by Supplier
Exhibit 5-25:
2005, Rest of Europe Orthopedic Bone Graft Substitutes Market, Share
by Supplier
6. BONE GROWTH
FACTORS MARKET
6.1 Introduction
to Bone Growth Factors
6.1.1 Bone Growth
Factor Families
6.1.2 Bone Growth
Factor Sources
6.1.3 Mechanisms
of Action
6.1.4 Effects on
Skeletal Cells and Tissue
6.1.5 Recombinant
Bone Growth Factors
6.2 Bone Growth
Factor Delivery Vehicles
6.2.1
Reverse-Phase Media
6.2.2
Osteoconductive Matrices
6.2.3
Gene-Activated Matrices
6.2.4 Biodegradable Microspheres
6.2.5 Membrane Barriers
6.2.6 Hydrogels
6.2.7 Products/Technologies
6.2.8 Placement
Volumes Forecast
6.2.9 Market
Forecast
6.3 Selected Bone
Growth Factors
6.3.1
Transforming Growth Factor-β Superfamily of Proteins
6.3.1.1
Transforming Growth Factor
6.3.1.1.1 Clinical Applications
6.3.1.1.2 Products/Technologies
6.3.1.1.3 Placement Volumes Forecast
6.3.1.1.4 Market Forecast
6.3.1.2 Bone
Morphogenic Proteins
6.3.1.2.1 Clinical Applications
6.3.1.2.2 Products/Technologies
6.3.1.2.3 Placement Volumes Forecast
6.3.1.2.4 Market Forecast
6.3.2 Fibroblast
Growth Factors
6.3.2.1 Clinical
Applications
6.3.2.2
Products/Technologies
6.3.2.3 Placement
Volumes Forecast
6.3.2.4 Market
Forecast
6.3.3
Platelet-Derived Growth Factors
6.3.3.1 Clinical
Applications
6.3.3.2
Products/Technologies
6.3.3.3 Placement
Volumes Forecast
6.3.3.4 Market
Forecast
6.3.4 Bone Marrow
Stromal Cell Antigen
6.3.4.1 Clinical
Applications
6.3.4.2
Products/Technologies
6.3.4.3 Placement
Volumes Forecast
6.3.4.4 Market
Forecast
6.3.5 Synthetic
Proteins
6.3.5.1 Clinical
Applications
6.3.5.2
Products/Technologies
6.3.5.3 Placement
Volumes Forecast
6.3.5.4 Market
Forecast
6.3.6 Other
Growth Factors
6.3.6.1
Insulin-Like Growth Factors
6.3.6.1.1 Clinical Applications
6.3.6.1.2 Products/Technologies
6.3.6.1.3 Placement Volumes Forecast
6.3.6.1.4 Market Forecast
6.3.6.2 LIM
Mineralization Protein-1
6.3.6.2.1 Clinical Applications
6.3.6.2.2 Products/Technologies
6.3.6.2.3 Placement Volumes Forecast
6.3.6.2.4 Market Forecast
6.4 Bone Growth
Factors Market Analysis
6.4.1 Market
Forecasts
6.4.1.1 Europe
6.4.1.2 France
6.4.1.3 Germany
6.4.1.4 Italy
6.4.1.5 Spain
6.4.1.6 United
Kingdom
6.4.1.7 Rest of
Europe
6.4.2 Competitive
Analysis
6.4.2.1 Europe
6.4.2.2 France
6.4.2.3 Germany
6.4.2.4 Italy
6.4.2.5 Spain
6.4.2.6 United
Kingdom
6.4.2.7 Rest of
Europe
Exhibit 6-1:
The TGF-β Superfamily
Exhibit 6-2:
Commonly Known Bone Growth Factors
Exhibit 6-3:
Identified Interleukins
Exhibit 6-4:
Reverse-Phase Media Market Forecast, 2004-2010
Exhibit 6-5:
Osteoconductive Matrices Market Forecast, 2004-2010
Exhibit 6-6:
Gene-Activated Matrices Market Forecast, 2004-2010
Exhibit 6-7:
Biodegradable Microspheres Market Forecast, 2004-2010
Exhibit 6-8:
Membrane Barriers Market Forecast, 2004-2010
Exhibit 6-9:
Hydrogels Market Forecast, 2004-2010
Exhibit 6-10:
The Transforming Growth Factor-Beta Superfamily
Exhibit 6-11:
Bone Growth Factor-B Protein Market Forecast, 2004-2010
Exhibit 6-12:
2006, Selected Bone Morphogenetic Proteins for Orthopedic
Applications
Exhibit 6-13:
Bone Morphogenic Proteins Market Forecast, 2004-2010
Exhibit 6-14:
Fibroblast Growth Factors Market Forecast, 2004-2010
Exhibit 6-15:
Platelet-Derived Growth Factors Market Forecast, 2004-2010
Exhibit 6-16:
Bone Marrow Stroma Cell Antigen Market Forecast, 2004-2010
Exhibit 6-17:
Synthetic Proteins Market Forecast, 2004-2010
Exhibit 6-18:
Insulin-Like Growth Factors Market Forecast, 2004-2010
Exhibit 6-19:
LIM Mineralization Protein-1 Market Forecast, 2004-2010
Exhibit 6-20:
Bone Growth Factors, European Market Forecast, 2004-2010
Exhibit 6-21:
Bone Growth Factors, France Market Forecast, 2004-2010
Exhibit 6-22:
Bone Growth Factors, Germany Market Forecast, 2004-2010
Exhibit 6-23:
Bone Growth Factors, Italy Market Forecast, 2004-2010
Exhibit 6-24:
Bone Growth Factors, Spain Market Forecast, 2004-2010
Exhibit 6-25:
Bone Growth Factors, United Kingdom Market Forecast, 2004-2010
Exhibit 6-26:
Bone Growth Factors, Rest of Europe Market Forecast, 2004-2010
Exhibit 6-27:
2005, European Orthopedic Bone Growth Factors Market, Share by
Supplier
Exhibit 6-28:
2005, France Orthopedic Bone Growth Factors Market, Share by
Supplier
Exhibit 6-29:
2005, Germany Orthopedic Bone Growth Factors Market, Share by
Supplier
Exhibit 6-30:
2005, Italy Orthopedic Bone Growth Factors Market, Share by Supplier
Exhibit 6-31:
2005, Spain Orthopedic Bone Growth Factors Market, Share by Supplier
Exhibit 6-32:
2005, United Kingdom Orthopedic Bone Growth Factors Market, Share by
Supplier
Exhibit 6-33:
2005, Rest of Europe Orthopedic Bone Growth Factors Market, Share by
Supplier
7. ARTHROSCOPIC
SURGERY PRODUCTS MARKETS
7.1 Arthroscopic
Surgery Procedures
7.1.1 Articular
Surface Repair
7.1.2 Ligament
Repair
7.1.3 Meniscal
Repair
7.1.4 Tendon
Repair
7.2 Tissue
Fixation Devices
7.2.1 Resorbable
Fixation Products
7.2.1.1
Products/Technologies
7.2.1.2 Placement
Volumes Forecast
7.2.1.3 Market
Forecast
7.2.2 Tissue
Fixation Devices Market Analysis
7.2.2.1 Market
Forecasts
7.2.2.1.1
Europe
7.2.2.1.2
France
7.2.2.1.3
Germany
7.2.2.1.4
Italy
7.2.2.1.5
Spain
7.2.2.1.6
United Kingdom
7.2.2.1.7 Rest of
Europe
7.2.2.2
Competitive Analysis
7.2.2.2.1
Europe
7.2.2.2.2
France
7.2.2.2.3
Germany
7.2.2.2.4
Italy
7.2.2.2.5
Spain
7.2.2.2.6
United Kingdom
7.2.2.2.7 Rest of
Europe
7.3 Arthroscopic
Suturing Devices
7.3.1 Suture
Anchors
7.3.1.1
Resorbable Products
7.3.1.1.1 Products/Technologies
7.3.1.1.2 Placement Volumes Forecast
7.3.1.1.3 Market Forecast
7.3.2 Meniscal
Repair Devices
7.3.2.1
Resorbable Products
7.3.2.1.1 Products/Technologies
7.3.2.1.2 Placement Volumes Forecast
7.3.2.1.3 Market Forecast
7.3.3
Arthroscopic Suturing Devices Market Analysis
7.3.3.1 Market
Forecasts
7.3.3.1.1
Europe
7.3.3.1.2
France
7.3.3.1.3
Germany
7.3.3.1.4 | 
